Atara Biotherapeutics, Inc. (ATRA) › Net IncomeAtara Biotherapeutics, Inc. (ATRA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$8.77M2014: -$28.01M2015: -$57.22M2016: -$79.05M2017: -$119.49M2018: -$230.70M2019: -$290.98M2020: -$306.62M2021: -$340.14M2022: -$228.30M2023: -$276.13M2024: -$85.40M2025: $32.69M$32.69M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$32.69M+138.3%2024-$85.40M+69.1%2023-$276.13M-20.9%2022-$228.30M+32.9%2021-$340.14M-10.9%2020-$306.62M-5.4%2019-$290.98M-26.1%2018-$230.70M-93.1%2017-$119.49M-51.2%2016-$79.05M-38.1%2015-$57.22M-104.3%2014-$28.01M-219.2%2013-$8.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share